Anika Therapeutics (ANIK) Institutional Ownership $14.95 +0.04 (+0.27%) Closing price 05/18/2026 04:00 PM EasternExtended Trading$14.95 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Anika Therapeutics (NASDAQ:ANIK)CurrentInstitutional OwnershipPercentage91.53%Number ofInstitutional Buyers(last 12 months)62TotalInstitutional Inflows(last 12 months)$21.81MNumber ofInstitutional Sellers(last 12 months)25TotalInstitutional Outflows(last 12 months)$23.88M Get ANIK Insider Trade Alerts Want to know when executives and insiders are buying or selling Anika Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ANIK Institutional Buying and Selling by Quarter Anika Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2026 Quantinno Capital Management LP125,826$1.82M0.0%+23.9%0.946% 5/14/2026 Renaissance Technologies LLC502,217$7.28M0.0%-2.6%3.773% 5/14/2026 Public Employees Retirement System of Ohio23,614$342K0.0%+51.4%0.177% 5/14/2026 Arrowstreet Capital Limited Partnership31,354$455K0.0%-40.8%0.236% 5/13/2026 Cetera Investment Advisers14,220$206K0.0%-13.6%0.107% 5/7/2026 Dimensional Fund Advisors LP458,847$6.65M0.0%-7.2%3.448% 5/5/2026 Bank of New York Mellon Corp39,767$577K0.0%-1.8%0.299% 5/5/2026 Hillsdale Investment Management Inc.25,400$368K0.0%N/A0.191% 4/30/2026 Hsbc Holdings PLC50,292$729K0.0%+4.0%0.378% 4/29/2026 R Squared Ltd50,184$728K0.4%+20.7%0.375% Get the Latest News and Ratings for ANIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anika Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/20/2026 Assenagon Asset Management S.A.46,586$675K0.0%+268.7%0.348% 3/20/2026 Hsbc Holdings PLC48,341$464K0.0%N/A0.361% 3/9/2026 Corient Private Wealth LLC32,224$310K0.0%+4.3%0.240% 2/19/2026 Invesco Ltd.25,272$243K0.0%+7.9%0.175% 2/19/2026 Corient Private Wealth LLC32,224$310K0.0%+4.3%0.223% 2/18/2026 Mercer Global Advisors Inc. ADV12,745$122K0.0%N/A0.088% 2/18/2026NewEdge Advisors LLC14,492$139K0.0%N/A0.100% 2/18/2026 XTX Topco Ltd22,252$214K0.0%+74.3%0.154% 2/18/2026 Quadrature Capital Ltd44,735$430K0.0%N/A0.310% 2/18/2026 Occudo Quantitative Strategies LP25,510$245K0.0%+152.5%0.177% 2/18/2026 Oxford Asset Management LLP16,620$160K0.1%N/A0.115% 2/18/2026 Millennium Management LLC26,154$251K0.0%-69.9%0.181% 2/18/2026 Man Group plc64,278$618K0.0%+335.0%0.446% 2/18/2026 Engineers Gate Manager LP40,276$387K0.0%+66.9%0.279% 2/18/2026 Boothbay Fund Management LLC534,507$5.14M0.1%-1.0%3.707% 2/17/2026 AQR Capital Management LLC69,280$666K0.0%+40.1%0.480% 2/17/2026 Cetera Investment Advisers16,455$158K0.0%-21.9%0.114% 2/17/2026 Jain Global LLC14,249$137K0.0%N/A0.099% 2/17/2026 Trexquant Investment LP107,307$1.03M0.0%+140.1%0.744% 2/17/2026 Jump Financial LLC20,121$193K0.0%N/A0.140% 2/17/2026 Public Employees Retirement System of Ohio15,592$150K0.0%+88.4%0.108% 2/17/2026 State of Wisconsin Investment Board49,596$477K0.0%+5.5%0.344% 2/17/2026 Diker Management LLC58,210$559K0.4%+2.4%0.404% 2/16/2026 Trigran Investments Inc.168,400$1.62M0.3%-89.6%1.168% 2/16/2026 Barclays PLC70,506$678K0.0%+119.8%0.489% 2/13/2026 Marshall Wace LLP87,188$838K0.0%+18.3%0.605% 2/13/2026 Advyzon Investment Management LLC48,296$464K0.1%+139.8%0.335% 2/13/2026 Jacobs Levy Equity Management Inc.195,585$1.88M0.0%+78.1%1.356% 2/13/2026 Charles Schwab Investment Management Inc.106,297$1.02M0.0%+2.3%0.737% 2/13/2026 State Street Corp336,543$3.23M0.0%+4.1%2.334% The REAL Reason Trump is Invading Iran (Ad)For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.2/13/2026 Ieq Capital LLC10,069$97K0.0%N/A0.070% 2/13/2026 Wells Fargo & Company MN14,675$141K0.0%+43.7%0.102% 2/12/2026 Jane Street Group LLC134,768$1.30M0.0%+171.0%0.935% 2/12/2026 Renaissance Technologies LLC515,717$4.96M0.0%-3.2%3.576% 2/12/2026 Dimensional Fund Advisors LP494,319$4.75M0.0%-17.8%3.428% 2/12/2026 Ironwood Investment Management LLC65,610$631K0.3%+132.7%0.455% 2/12/2026 Nuveen LLC53,202$511K0.0%+75.2%0.369% 2/11/2026 Cerity Partners LLC31,775$305K0.0%+5.2%0.220% 2/11/2026 Los Angeles Capital Management LLC14,150$138K0.0%-45.8%0.098% 2/10/2026 Goldman Sachs Group Inc.164,926$1.59M0.0%+153.8%1.144% 2/9/2026 Geode Capital Management LLC325,522$3.13M0.0%-3.0%2.257% 2/6/2026 GSA Capital Partners LLP122,062$1.17M0.1%+192.4%0.846% 2/5/2026 Williams & Novak LLC14,193$136K0.1%+30.9%0.098% 2/3/2026 Indivisible Partners50,402$484K0.1%N/A0.350% 2/2/2026 Capital Management Corp VA500,465$4.81M0.8%-9.2%3.471% 2/2/2026 Strs Ohio15,600$150K0.0%+12.2%0.108% 2/2/2026 Objectivity Squared LLC31,575$303K0.2%N/A0.219% 1/30/2026 R Squared Ltd41,581$400K0.2%+141.7%0.288% 1/29/2026 Inscription Capital LLC12,666$122K0.0%N/A0.088% 1/26/2026 CWM LLC8,537$82K0.0%+14.5%0.059% 1/22/2026 Massachusetts Financial Services Co. MA46,378$446K0.0%-3.2%0.322% 1/9/2026 Assenagon Asset Management S.A.12,635$121K0.0%-72.4%0.088% 1/1/2026 Tudor Investment Corp ET AL11,355$107K0.0%N/A0.079% 12/9/2025 Tudor Investment Corp ET AL11,355$107K0.0%N/A0.079% 11/17/2025 Jacobs Levy Equity Management Inc.109,814$1.03M0.0%-8.0%0.761% 11/17/2025 PharVision Advisers LLC41,386$389K0.2%N/A0.287% 11/17/2025 Quarry LP7,558$71K0.0%N/A0.052% 11/17/2025 Qube Research & Technologies Ltd17,428$164K0.0%-19.5%0.121% 11/17/2025 Nantahala Capital Management LLC20,961$197K0.0%N/A0.145% 11/17/2025 Millennium Management LLC86,874$817K0.0%-35.0%0.602% 11/17/2025 Citadel Advisors LLC19,383$182K0.0%-31.4%0.134% 11/17/2025Bank of America Corp DE29,682$279K0.0%-3.8%0.206% 11/17/2025 Boothbay Fund Management LLC539,642$5.07M0.1%+1.9%3.742% 11/17/2025 Ameriprise Financial Inc.32,989$310K0.0%-20.2%0.229% 11/14/2025 Man Group plc14,778$139K0.0%+11.4%0.102% 11/14/2025 Occudo Quantitative Strategies LP10,103$95K0.0%N/A0.070% 11/14/2025 Two Sigma Investments LP79,921$751K0.0%N/A0.554% 11/14/2025Cove Street Capital LLC101,956$958K1.3%+37.6%0.707% 11/13/2025 BNP Paribas Financial Markets15,263$143K0.0%+1,071.4%0.106% 11/12/2025 Trigran Investments Inc.1,621,215$15.24M2.8%-20.4%11.242% 11/12/2025 Dimensional Fund Advisors LP601,163$5.65M0.0%-3.5%4.169% 11/12/2025 R Squared Ltd17,206$162K0.1%+27.0%0.119% 11/10/2025 Advyzon Investment Management LLC20,136$189K0.0%N/A0.140% 11/7/2025 GSA Capital Partners LLP41,743$392K0.0%N/A0.290% 11/7/2025Vanguard Group Inc.780,663$7.34M0.0%+0.2%5.415% 11/5/2025 Envestnet Asset Management Inc.130,809$1.23M0.0%+7.8%0.907% 11/4/2025 Capital Management Corp VA551,248$5.18M0.8%+34.8%3.823% 10/30/2025 Strs Ohio13,900$131K0.0%N/A0.096% 10/30/2025 Williams & Novak LLC10,840$102K0.1%N/A0.075% 10/15/2025 CWM LLC7,457$70K0.0%+526.6%0.052% Your $29.97 book is free today (Ad)Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.Normally $29.97. Today it's free. Grab your copy now.10/7/2025 Assenagon Asset Management S.A.45,843$431K0.0%N/A0.318% 8/15/2025 Opaleye Management Inc.588,797$6.23M1.3%+49.1%4.083% 8/15/2025 Man Group plc13,268$140K0.0%N/A0.092% 8/15/2025 Gallagher Fiduciary Advisors LLC13,347$141K0.0%+21.5%0.093% 8/15/2025 Engineers Gate Manager LP16,468$174K0.0%-26.7%0.114% 8/15/2025 Bridgeway Capital Management LLC17,500$185K0.0%N/A0.121% 8/15/2025Bank of America Corp DE30,862$327K0.0%-6.8%0.214% 8/15/2025 Ameriprise Financial Inc.41,362$438K0.0%+4.6%0.287% 8/14/2025 Jane Street Group LLC22,871$242K0.0%+31.6%0.159% 8/14/2025 Qube Research & Technologies Ltd21,658$229K0.0%-49.1%0.150% ANIK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANIK shares? During the previous two years, 112 institutional investors and hedge funds held shares of Anika Therapeutics. The most heavily invested institutionals were Caligan Partners LP ($35.45M), Vanguard Group Inc. ($7.34M), Renaissance Technologies LLC ($7.28M), Alta Fundamental Advisers LLC ($7.08M), Dimensional Fund Advisors LP ($6.65M), Opaleye Management Inc. ($6.23M), and Acadian Asset Management LLC ($6.08M).Learn more on Anika Therapeutics' institutional investors. What percentage of Anika Therapeutics' stock is owned by institutional investors? 91.53% of Anika Therapeutics' stock is owned by institutional investors. Learn more on ANIK's institutional investor holdings. Which institutional investors have been buying Anika Therapeutics' stock? Of the 94 institutional investors that purchased Anika Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alta Fundamental Advisers LLC ($404.35K), Capital Management Corp VA ($260.90K), Jacobs Levy Equity Management Inc. ($222.05K), Opaleye Management Inc. ($193.80K), Stonepine Capital Management LLC ($177.27K), GSA Capital Partners LLP ($122.06K), and Acadian Asset Management LLC ($121.45K). How much institutional buying is happening at Anika Therapeutics? Institutional investors have bought a total of 2,148,406 shares in the last 24 months. This purchase volume represents approximately $21.81M in transactions. Which of Anika Therapeutics' major shareholders have been selling company stock? Of the 24 institutional investors that sold Anika Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Trigran Investments Inc. ($1.87M), Dimensional Fund Advisors LP ($164.24K), Millennium Management LLC ($107.52K), Capital Management Corp VA ($50.78K), Assenagon Asset Management S.A. ($33.21K), Renaissance Technologies LLC ($30.80K), and Arrowstreet Capital Limited Partnership ($27.24K). How much institutional selling is happening at Anika Therapeutics? Institutional investors have sold a total of 2,440,463 shares in the last 24 months. This volume of shares sold represents approximately $23.88M in transactions. Related Companies Annovis Bio Major Shareholders QuidelOrtho Major Shareholders Cerus Major Shareholders OraSure Technologies Major Shareholders Utah Medical Products Major Shareholders West Pharmaceutical Services Major Shareholders Align Technology Major Shareholders Cooper Companies Major Shareholders Merit Medical Systems Major Shareholders ICU Medical Major Shareholders This page (NASDAQ:ANIK) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
